Bio-Path Holdings ( NASDAQ: BPTH ) entered an agreement for the issuance and sale of an aggregate of 1,809,955 shares of its common stock, series A warrants and short-term series B warrants at a purchase price of $2.21 per share of common stock. The series A warrants and short-term series B warrants will have an exercise price of $2.
00 per share and will be exercisable immediately upon issuance. The gross proceeds to the company from the offering are expected to be approximately $4.0 million.
Source: Press Release More on Bio-Path Bio-Path Holdings Inc. (BPTH) Q1 2024 Earnings Call Transcript Bio-Path Holdings Inc. (BPTH) Q4 2023 Earnings Call Transcript Bio-Path announces $1.
2M registered direct offering priced at-the-market Bio-Path shares rally after clinical trial progress of BP1002 Seeking Alpha’s Quant Rating on Bio-Path.
